Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience January 22, 2016
Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey November 23, 2015
Comparative phenomenology of psilocybin experiences in research and non-research settings November 1, 2015
Long-term follow-up of psilocybin-facilitated smoking cessation: Abstinence outcomes and qualitative analysis of participant accounts November 1, 2015
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin October 6, 2015
